Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-07-003122
Filing Date
2007-03-02
Accepted
2007-03-02 16:12:44
Documents
10
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y31092e10vk.htm 10-K 1543481
2 EX-12.1: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES y31092exv12w1.htm EX-12.1 28773
3 EX-21.1: SUBSIDIARIES y31092exv21w1.htm EX-21.1 3224
4 EX-23.0: CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM y31092exv23w0.htm EX-23.0 4958
5 EX-31.1: CERTIFICATION y31092exv31w1.htm EX-31.1 9281
6 EX-31.2: CERTIFICATION y31092exv31w2.htm EX-31.2 9176
7 EX-32.1: CERTIFICATION y31092exv32w1.htm EX-32.1 4770
8 EX-32.2: CERTIFICATION y31092exv32w2.htm EX-32.2 4547
9 GRAPHIC y31092y3109200.gif GRAPHIC 1495
10 GRAPHIC y31092y3109201.gif GRAPHIC 8034
  Complete submission text file 0000950123-07-003122.txt   1623377
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12957 | Film No.: 07667863
SIC: 2836 Biological Products, (No Diagnostic Substances)